CANB

NASDAQ

Can B Corp.

News25/Ratings0

Can B Corp. develops, manufactures, and sells cannabidiol (CBD) based products in the United States. The company provides CBD products derived from hemp, including oils, creams, moisturizers, isolate, gel caps, spa products, concentrates, and life style products through its Website and vending machines, and other medical professionals. It offers its products under the Canbiola, Nu Wellness, Seven Chakras, and Pure Leaf Oil brands. The company was formerly known as Canbiola Inc. and changed its name to Can B Corp. in February 2020. Can B Corp. was incorporated in 2005 and is based in Hicksville, New York.

Latest news

25 items

281dSEC
SEC Form 15-12G filed by Can B Corp.
15-12G - Can B Corp (0001509957) (Filer)
391dSEC
SEC Form NT 10-K filed by Can B Corp.
NT 10-K - Can B Corp (0001509957) (Filer)
451dSEC
SEC Form EFFECT filed by Can B Corp.
EFFECT - Can B Corp (0001509957) (Filer)
465dSEC
SEC Form POS AM filed by Can B Corp.
POS AM - Can B Corp (0001509957) (Filer)
520dSEC
SEC Form 10-Q filed by Can B Corp.
10-Q - Can B Corp (0001509957) (Filer)
525d13D/G
Amendment: SEC Form SC 13G/A filed by Can B Corp.
SC 13G/A - Can B Corp (0001509957) (Subject)
526dSEC
SEC Form NT 10-Q filed by Can B Corp.
NT 10-Q - Can B Corp (0001509957) (Filer)
540dPR
Can B Corp. Announces Holding Company Reorganization With Nascent Pharma Holdings, Inc. to Become the Publicly-Traded Parent Company
Primary Focus on Protecting and Commercializing Cannabis Patents HICKSVILLE, N.Y., Oct. 30, 2024 (GLOBE NEWSWIRE) -- Can B Corp. (OTCQB:CANB) ("Can B" or the "Company") today announced that it has implemented a reorganization in which a new holding company, Nascent Pharma Holdings, Inc., has become the publicly-traded parent of Can B and its subsidiaries. As a result of the reorganization, existing shares of Can B stock have been automatically converted, on a one-for-one basis, into shares of common stock of Nascent Pharma Holdings, Inc. The Board and executive officers of Can B will continue in the same roles at Nascent Pharma Holdings, Inc. In March 2024, Can B announced that
542dSEC
SEC Form 15-12G filed by Can B Corp.
15-12G - Can B Corp (0001509957) (Filer)
542dSEC
Can B Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Material Modification to Rights of Security Holders
8-K - Can B Corp (0001509957) (Filer)
612dSEC
SEC Form 10-Q filed by Can B Corp.
10-Q - Can B Corp (0001509957) (Filer)
617dSEC
SEC Form NT 10-Q filed by Can B Corp.
NT 10-Q - Can B Corp (0001509957) (Filer)
666dNEWS
Canadian CanadaBis Reports C$3.97M Net Revenue In Q3 2024, 26% Decline YoY
Alberta-based vertically integrated cannabis operator CanadaBis (CVE:CANB) announced the results from their Q3 2024 for the company and its subsidiaries Stigma Pharmaceuticals Inc., Stigma Grow, Stigma Roots, Indicative Collection and Goldstream Cannabis Inc. Despite showing a decrease of 26% YoY for Q3, the company highlighted the fact that it is its tenth consecutive quarter generating revenue. The positive results come amid a challenging economy for Cannabis in Canada, which pushed the company to seek increased operational efficiency. “Canadabis Capital’s performance in Q3 2024 was robust, driven by our strategic investments and continuous efforts to optimize our operational efficie
674dSEC
Can B Corp. filed SEC Form 8-K: Costs Associated with Exit or Disposal Activities
8-K - Can B Corp (0001509957) (Filer)
692dSEC
SEC Form 8-K filed by Can B Corp.
8-K - Can B Corp (0001509957) (Filer)
703dSEC
SEC Form 10-Q filed by Can B Corp.
10-Q - Can B Corp (0001509957) (Filer)
717dSEC
SEC Form 8-K filed by Can B Corp.
8-K - Can B Corp (0001509957) (Filer)
738dSEC
SEC Form 10-K filed by Can B Corp.
10-K - Can B Corp (0001509957) (Filer)
755dSEC
SEC Form NT 10-K filed by Can B Corp.
NT 10-K - Can B Corp (0001509957) (Filer)
763dSEC
Can B Corp. filed SEC Form 8-K: Creation of a Direct Financial Obligation
8-K - Can B Corp (0001509957) (Filer)
764dSEC
Can B Corp. filed SEC Form 8-K: Completion of Acquisition or Disposition of Assets
8-K - Can B Corp (0001509957) (Filer)
778dSEC
Can B Corp. filed SEC Form 8-K: Other Events
8-K - Can B Corp (0001509957) (Filer)
783dSEC
Can B Corp. filed SEC Form 8-K: Other Events
8-K - Can B Corp (0001509957) (Filer)
799d13D/G
SEC Form SC 13G/A filed by Can B Corp. (Amendment)
SC 13G/A - Can B Corp (0001509957) (Subject)
799d13D/G
SEC Form SC 13G/A filed by Can B Corp. (Amendment)
SC 13G/A - Can B Corp (0001509957) (Subject)